Event info
Date:17 Apr
Time:09:00 to 16:00
Venue:

Boost Seminar – Attracting Investors and Industry

17 April 2012 / Ørestad / Denmark
Medicon Valley Alliance in cooperation with DNB invites you to participate in a network meeting on how to attract investors and industry partners to a life science company. At the meeting you will also have the opportunity to present you technology / business plan to any of the cooperating partners in a 1-1 setting.
Future Success
Attracting interest from investors and industry partners lies at the core of most successful life science ventures. In the current funding environment, where there is simply not enough capital available to fund all the promising projects, these processes are more important than ever: Success in creating investor/partner interest is likely to distinguish the future winners from those companies that will not be given the chance to exploit the full potential of their technologies/products.
Hear Erik Lund describe how Merck looks at licensing, Erik Amble from NeoMed shed light on the venture capitalists’ point of view, and ex-entrepreneur Øyvind W. Brekke discuss how DNB as a bank can play a role even for early-stage companies.
Following the presentations, you will have the opportunity to discuss your technology / business plan to any of the presenters in 1-1 meetings.
Program

09.00-09.30Registration and networking
09.30-10.00Licensing at Merck
Erik Lund, Director, Worldwide Licensing, Merck
10.00-10.30What NeoMed looks for when investing in venture-stage companies
Erik Amble, Managing Partner, NeoMed Management
10.30-10.50How DNB as a bank can add value in the pre-commercial development stage
Øyvind W. Brekke, Senior Advisor, Section International Healthcare, DNB
11.00-16.001-1 meetings / networking / lunch

Venue
Auditorium, Arne Jacobsens Allé 15-17, 2300 Copenhagen S, Denmark.
In coorperation with

DNB Bank ASA is the largest financial services group in Norway, and the only Nordic bank with an international focus on Healthcare. DNB has a large portfolio of European and US Pharma and Medtech clients who look to DNB for insight into future partnering/acquisition opportunities in the Nordic countries.

 
Registration
Participation is free of charge (late cancellation/no-show fee DKK 500).
Please register by filling in the form below, latest Thursday 12 April.
We use the input data as it is written for name tags and list of participants, and the email for further information prior to the boost seminar.
Registration has been closed